Back to top

Enanta Pharmaceuticals (ENTA) Looks Good: Stock Adds 6.2%
November 26, 2013

Read MoreHide Full Article
Enanta Pharmaceuticals, Inc. (ENTA - Free Report) was a big mover last session, as the company saw its shares rise by over 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company, as the stock is now up 24.2% in the past one-month time frame.

This biotechnology stock has seen a lack of estimate revisions in the past one month. Thus, the Zacks Consensus Estimate has remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Enanta Pharmaceuticals currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.

Apart from Enanta Pharmaceuticals, investors interested in the med-drugs industry may also consider stocks such as Jazz Pharmaceuticals Public Limited Company (JAZZ - Free Report) , Questcor Pharmaceuticals, Inc. and Sucampo Pharmaceuticals, Inc. (SCMP - Free Report) . All these stocks carry the same rank as Enanta Pharmaceuticals.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Enanta Pharmaceuticals, Inc. (ENTA) - free report >>

Jazz Pharmaceuticals PLC (JAZZ) - free report >>

Sucampo Pharmaceuticals, Inc. (SCMP) - free report >>

You May Like